Okyo PharmaOKYO
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 8 institutions reported holding Okyo Pharma Ltd. (OKYO) in their 13F filings, up 3 from Q2 2025. 4 opened new positions and 1 sold out. The largest holders were Dauntless Investment Group, LLC ($4.8M), Northern Trust Corp. ($114K) and Renaissance Technologies ($82K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Okyo Pharma Ltd.
- CUSIP
- G6724L116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $228K |
| Exits | 1 | $296 |
All 13F filers, Q2 2025 → Q3 2025: 113,865 shares bought and 313,847 shares sold, net −199,982 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Dauntless Investment Group, LLC | 12.71% | Reduce -11.5% | 2,422,048 | $4.8M |
| Northern Trust Corp. | 0.00% | New | 57,158 | $114K |
| Renaissance Technologies | 0.00% | New | 41,200 | $82K |
| Citadel Advisors | 0.00% | New | 15,355 | $31K |
| Cerity Partners LLC | 0.00% | No change | 12,812 | $26K |
| Geode Capital Management, LLC | 0.00% | No change | 12,090 | $24K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | No change | 10,000 | $20K |
| Osaic Holdings, Inc. | 0.00% | New | 152 | $304 |
"% of holder's portfolio" is OKYO's weight in each manager's 13F, not the share of Okyo Pharma Ltd. the manager owns.